Transaction · 0001193125-26-361183

Boyle James M

Boyle James M, CEO, reported a transaction classified as grant at Medline Inc. involving 764252.000000 shares. Reported holdings after the transaction were 764252.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACEO
MDLNMedline Inc.
Trade date
Aug 19, 2026
Filing date
Aug 21, 2026
View on SEC Insider profile
Estimated value—Shares × reported price
Shares traded764kPrice unknown
Holdings after764kIndirect · See Footnotes
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

MDLN price since this filing

Daily closing prices, with the filing date and available return windows
MDLN · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +13.5%1w ago +3.6%1d ago -0.4%
Returns since7d +3.0%30d -7.6%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001193125-26-361183
Incentive Units of Medline Holdings, LP
Transaction date
Aug 19, 2026
Filed Aug 21, 2026, 08:30 PM · 2d delay
Shares
764,252 sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
764,252 sh
Indirect · See Footnotes

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Large Holdings Increase
Filing-only score

-20 points

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • missing_price-8 points

    price_cents is null

    Missing price reduces confidence in value-based signals.
Missing facts
  • price_cents
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Represents performance-based incentive units of Medline Holdings, LP ("Incentive Units"), that were earned as a result of the achievement of certain performance criteria as certified by the compensati…

  2. F2

    Incentive Units are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of Common U…

  3. F3

    (Continued from Footnote 2 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of the Exchange Agreement. These Incentive Units have no…

Original filing · 0001193125-26-361183
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

MDLN